Accelerated Phase Chronic Myelogenous Leukemia

Oncology·MeSH: Leukemia, Myeloid, Accelerated Phase

11 drugs in development·3 companies·0 clinical trials

Drug Pipeline by Phase

Phase 3(7)

Drug	Company
Blinatumomab	Assertio Holdings, Inc. (ASRT)
Cytarabine	Assertio Holdings, Inc. (ASRT)
Filgrastim	Assertio Holdings, Inc. (ASRT)
Liposome-encapsulated Daunorubicin-Cytarabine	Assertio Holdings, Inc. (ASRT)
Ponatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ponatinib Hydrochloride	Assertio Holdings, Inc. (ASRT)
Vincristine	Assertio Holdings, Inc. (ASRT)

Phase 2(2)

Drug	Company
Pegfilgrastim	Assertio Holdings, Inc. (ASRT)
Ponatinib	Assertio Holdings, Inc. (ASRT)

Phase 1(2)

Drug	Company
Cytarabine	Structure Therapeutics Inc. (GPCR)
Vincristine	Structure Therapeutics Inc. (GPCR)

Full trial data, competitive analysis, and AI-powered pipeline tracking.